Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort.
about
Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patientsThe Association between Dystemperament and Prevention of Diseases: A Systematic ReviewPsychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosisClinical characteristics of heavy and non-heavy smokers with schizophrenia.Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness.Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden.Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trialDietary, lifestyle and pharmacogenetic factors associated with arteriole endothelial-dependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs).Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivityRelative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study.Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study.Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence.Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial.A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewPrevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health SurveyPrimary care-based educational interventions to decrease risk factors for metabolic syndrome for adults with major psychotic and/or affective disorders: a systematic review.Atypical antipsychotic use is an independent predictor for the increased mean platelet volume in patients with schizophrenia: A preliminary studyEffectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.Quality assessment of physical activity recommendations within clinical practice guidelines for the prevention and treatment of cardio-metabolic risk factors in people with schizophrenia.International Organization of Physical Therapy in Mental Health consensus on physical activity within multidisciplinary rehabilitation programmes for minimising cardio-metabolic risk in patients with schizophrenia.Management of schizophrenia in late life with antipsychotic medications: a qualitative review.Diabetes and Schizophrenia.Correlates of physical activity in people living with psychotic illness.Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.Health for smokers with schizophrenia - a struggle to maintain a dignified life.Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia.Mental health in primary care: perceptions of augmented care for individuals with serious mental illness.Implementing a mental health and primary care partnership program in Placer County, California.No association between genetic or epigenetic variation in insulin growth factors and antipsychotic-induced metabolic disturbances in a cross-sectional sample.Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.Quality of life and physical activity levels in outpatients with schizophrenia.Metabolic syndrome: differences between psychiatric and internal medicine patients.Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in Singapore.The functional exercise capacity is correlated with global functioning in patients with schizophrenia.Preventing breast cancer in women with schizophrenia.Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review.
P2860
Q27027832-8C1F6BE9-A00E-40AE-B91D-1FFC5F9356A6Q28070147-229F026C-93E8-4488-BF67-73FFAFA18475Q30723937-8C7D4537-FE9D-410D-9A20-815D4C9A8AD2Q33775576-CEE81BC2-81EB-4F01-98D3-34DF75DA4114Q33889282-93093CDC-6EAA-4DEF-B500-CE6165E62034Q34571634-3B7E239E-B5C6-451E-9872-C9F61C8356C5Q35016170-8C6B0F37-7801-4A47-8EA5-34BEE56BCBB0Q35019136-5E46453E-C4AC-48C2-B30F-2290F951539DQ35116048-0560CC67-45D3-42F2-8B48-F3013D1BA819Q35704853-0DE18C33-5DEA-4B2D-A09A-B83E8CE732A0Q35744928-0BC03D13-01A7-4CD9-93C2-2559C3C8B276Q35834883-63C4A5EB-7506-4EF2-919B-ED61D90D3675Q35897524-45C72A83-FB47-45F8-AAF2-4AAEF1E4A821Q36149346-A9796805-E3A0-475D-92AA-F34449ABF9FDQ36600804-6BA78034-518B-46CA-900D-316D9034C708Q36600817-9CEC4155-4D92-4AF5-83DA-7FDDEAE76ECDQ36621075-D1B3AA02-C224-4880-AB53-2580A1E99634Q37190653-EFE9791F-840F-4CCA-B34C-EC9C00370B18Q37236168-9A0D9DDB-F94B-4191-B35B-DA6218239F97Q37424916-19E8473F-68E7-4FF0-BBBB-C7DB1ED52B30Q37498113-17296C50-CA26-4B78-B3CD-FDD1FAE06A88Q37583967-40041CDC-678B-47EF-BED8-57E6C218A871Q37892448-DC5F7A2D-90EF-4397-B666-A6BC21D922DEQ37940519-BA7EBBF7-8C85-4488-B8BA-2E2C4174226FQ37960898-673621EA-DE9B-4DB7-81E9-F694747564BEQ38709352-53A8C7A2-FE9D-4073-BF80-B1A39970A5D8Q38863143-10E1535A-687C-4EE1-B750-D77ABB797CB8Q41477685-B6CF6D7C-7C89-4AA5-8698-D1355867FB47Q41749556-F9632347-43D6-4BD5-BE56-2CBFCCDA1609Q43429817-914C7E3E-803F-465D-9ED5-21834DFEF063Q44896059-D6054A37-7A86-47D7-9D5E-9116AFFC10EAQ46152710-6087801B-EDC6-42F2-8674-35D2E05D94F5Q46195221-2A12050E-FB33-4ADA-B4D4-522BEFD529E6Q47274758-3E604510-A2C6-4E04-A2E1-42DAB2F837D5Q47844264-0DF453DC-8CBB-4B57-9512-FDA88C94C605Q48422028-07673A14-4393-4F50-A5A1-E46DEB92D4C3Q50751012-26ACE191-DA46-4015-B6AD-B78023487E1EQ51368998-7E5B2844-84A8-47F1-B69B-8B7A04F1CACAQ51832889-9969BAE3-6F3A-4EF3-B7E4-BA47C71BD8D6Q52579281-757DE5DC-C1C2-42C7-ABCC-B4B69FB921C1
P2860
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@en
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@nl
type
label
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@en
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@nl
prefLabel
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@en
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@nl
P2093
P1476
Healthy lifestyle habits and 1 ...... CLAMORS schizophrenia cohort.
@en
P2093
Javier Rejas
Julio Bobes
Margarida Garcia-Garcia
P304
P356
10.1016/J.SCHRES.2010.02.1030
P407
P50
P577
2010-03-09T00:00:00Z